Cargando…
A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study
BACKGROUND: There is renewed interest in magnetic hyperthermia as a treatment modality for cancer, especially when it is combined with other more traditional therapeutic approaches, such as the co-delivery of anticancer drugs or photodynamic therapy. METHODS: The influence of bimagnetic nanoparticle...
Autores principales: | Balivada, Sivasai, Rachakatla, Raja Shekar, Wang, Hongwang, Samarakoon, Thilani N, Dani, Raj Kumar, Pyle, Marla, Kroh, Franklin O, Walker, Brandon, Leaym, Xiaoxuan, Koper, Olga B, Tamura, Masaaki, Chikan, Viktor, Bossmann, Stefan H, Troyer, Deryl L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859385/ https://www.ncbi.nlm.nih.gov/pubmed/20350328 http://dx.doi.org/10.1186/1471-2407-10-119 |
Ejemplares similares
-
Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model
por: Basel, Matthew T, et al.
Publicado: (2012) -
Magnetic-Fe/Fe(3)O(4)-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages
por: Wang, Hongwang, et al.
Publicado: (2012) -
Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells
por: Wang, Lei, et al.
Publicado: (2012) -
Synergy of Iron Chelators and Therapeutic Peptide Sequences Delivered via a Magnetic Nanocarrier
por: Abayaweera, Gayani S., et al.
Publicado: (2017) -
Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection
por: Udukala, Dinusha N, et al.
Publicado: (2016)